{"entity":{"type":"insider","cik":"0001306134","url":"/insider/0001306134","json_url":"/insider/0001306134.json","name":"ProQuest Associates III LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2007-01-26","last":"2016-01-29","span_basis":"filed_date"},"name_variants":[{"name":"ProQuest Associates III LLC","source":"filing","n_filings":5,"first_seen":"2007-01-26","last_seen":"2016-01-29"}],"transactions":[{"id":3355203,"accession":"0000932440-16-000309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000932440-16-000309","line_url":"/filing/0000932440-16-000309#line-1","is_derivative":false,"issuer_cik":"0001033508","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001033508","owner_cik":null,"owner_name":"ProQuest Associates IV LLC; ProQuest Investments IV, L.P.; ProQuest Investments III, L.P.; SCHREIBER ALAIN; Moorin Jay; ProQuest Associates III LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":393700.0,"shares_display":"393,700","price_per_share":6.35,"price_display":"6.35","price_state":"stated","total_value":2499995.0,"total_display":"2,499,995.00","shares_owned_after":5062363.0,"shares_owned_after_display":"5,062,363","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-01-27","filed_date":"2016-01-29","scope":"insider"},{"id":8856544,"accession":"0000932440-15-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000932440-15-000034","line_url":"/filing/0000932440-15-000034#line-1","is_derivative":false,"issuer_cik":"0001033508","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001033508","owner_cik":null,"owner_name":"ProQuest Associates III LLC; ProQuest Associates IV LLC; ProQuest Investments IV, L.P.; Moorin Jay; ProQuest Investments III, L.P.; SCHREIBER ALAIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":811966.0,"shares_display":"811,966","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":4750001.1,"total_display":"4,750,001.10","shares_owned_after":4668663.0,"shares_owned_after_display":"4,668,663","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-23","filed_date":"2015-01-23","scope":"insider"},{"id":7006107,"accession":"0000932440-14-000212","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000932440-14-000212","line_url":"/filing/0000932440-14-000212#line-5","is_derivative":false,"issuer_cik":"0001033508","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001033508","owner_cik":null,"owner_name":"ProQuest Investments III, L.P.; ProQuest Associates III LLC; ProQuest Associates IV LLC; SCHREIBER ALAIN; ProQuest Investments IV, L.P.; Moorin Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1120833.0,"shares_display":"1,120,833","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":6724998.0,"total_display":"6,724,998.00","shares_owned_after":3856697.0,"shares_owned_after_display":"3,856,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-29","filed_date":"2014-06-02","scope":"insider"},{"id":7170540,"accession":"0000932440-10-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000932440-10-000071","line_url":"/filing/0000932440-10-000071#line-1","is_derivative":false,"issuer_cik":"0001033508","issuer_name":"NOVADEL PHARMA INC","issuer_ticker":"NVDL","issuer_name_source":null,"issuer_url":"/issuer/0001033508","owner_cik":null,"owner_name":"SCHREIBER ALAIN; ProQuest Associates III LLC; Moorin Jay; ProQuest Investments III, L.P.; PROQUEST INVESTMENTS II ADVISORS FUND LP; PROQUEST INVESTMENTS II LP; PROQUEST ASSOCIATES II LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4848485.0,"shares_display":"4,848,485","price_per_share":0.165,"price_display":"0.16","price_state":"stated","total_value":800000.025,"total_display":"800,000.02","shares_owned_after":34353138.0,"shares_owned_after_display":"34,353,138","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-31","filed_date":"2010-04-01","scope":"insider"},{"id":7635040,"accession":"0000932440-07-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000932440-07-000051","line_url":"/filing/0000932440-07-000051#line-1","is_derivative":false,"issuer_cik":"0001043873","issuer_name":"NOVADEL PHARMA INC","issuer_ticker":"NVD","issuer_name_source":null,"issuer_url":"/issuer/0001043873","owner_cik":null,"owner_name":"ProQuest Investments III, L.P.; ProQuest Associates III LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":763449.0,"shares_display":"763,449","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":1107001.05,"total_display":"1,107,001.05","shares_owned_after":4974426.0,"shares_owned_after_display":"4,974,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-01-05","filed_date":"2007-01-26","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001261249","name":"AGILE THERAPEUTICS INC","url":"/issuer/0001261249","role":"Ten percent owner","n_filings":3,"first_seen":"2014-06-02","last_seen":"2016-01-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001043873","name":"NOVADEL PHARMA INC","url":"/issuer/0001043873","role":"Ten percent owner","n_filings":2,"first_seen":"2007-01-26","last_seen":"2010-04-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001306134","retrieved_at":"2026-08-21T18:15:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}